Clearance of platelet microparticles in vivo

At present, little is known about the clearance of platelet-derived microparticles (PMP) in human blood, as due to ethical considerations infusion experiments with labeled microparticles are delicate. Therefore, we investigated the kinetics of PMP, which are abundantly present in apheresis platelet...

Full description

Saved in:
Bibliographic Details
Published in:Platelets (Edinburgh) Vol. 22; no. 2; pp. 111 - 116
Main Authors: Rank, A., Nieuwland, R., Crispin, A., Grützner, S., Iberer, M., Toth, B., Pihusch, R.
Format: Journal Article
Language:English
Published: England Informa UK Ltd 01-03-2011
Taylor & Francis
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:At present, little is known about the clearance of platelet-derived microparticles (PMP) in human blood, as due to ethical considerations infusion experiments with labeled microparticles are delicate. Therefore, we investigated the kinetics of PMP, which are abundantly present in apheresis platelet concentrates (PC), following platelet transfusion in severe thrombocytopenic patients (n = 11). PMP were double-stained with annexin V and cell-specific antibodies (anti-CD61, anti-CD63 or anti-CD62P, respectively) and detected by flow cytometry before and after transfusion of a single PC at fixed time intervals. Upon transfusion, the plasma levels of MP binding annexin V (2.5-fold), PMP (CD61+; 2.9-fold), and PMP from activated platelets (CD63+; 1.9-fold) or P-selectin (2.5-fold) increased immediately. The plasma levels of MP decreased with a half life of 5.8 hours (annexin V; 95% CI: 1.8-18.3) and 5.3 hours (CD61; 95% CI: 2.0-14.2). This is the first report in which the half life time of transfused PMP has been investigated in humans.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0953-7104
1369-1635
DOI:10.3109/09537104.2010.520373